| |
AIMAH
| |
Non-AIMAH
|
---|
|
Dose
|
n
|
Partial response (%)
|
Full response (%)
|
Correlation with in vivotest
|
n
|
Partial response (%)
|
Full response (%)
|
---|
ACTH1-24
|
50 pg/ml
|
7
|
2 (29%)
|
4 (57%)
|
0.30
|
5
|
1 (20%)
|
4 (80%)
|
ACTH1-24
|
500 pg/ml
|
10
|
3 (30%)
|
6 (60%)
|
0.07
|
18
|
1 (6%)
|
16 (89%)
|
FSK
|
1 μM
|
8
|
0
|
7 (88%)
|
0.29
|
9
|
0
|
7 (78%)
|
AngII
|
10 nM
|
2
|
0
|
0
|
n.a. #
|
2
|
1 (50%)
|
1 (50%)
|
AVP
|
10 nM
|
6
|
2 (33%)
|
1 (17%)
|
−0.72†; -0.50#
|
4
|
1 (25%)
|
0
|
AVP
|
100 nM
|
4
|
1 (25%)
|
1 (25%)
|
−1.00†; -0.80#
|
3
|
1 (33%)
|
0
|
Desmopressin
|
10 nM
|
5
|
0
|
0
|
−0.80
|
3
|
0
|
0
|
Metoclopramide
|
1 μM
|
7
|
0
|
2 (29%)
|
0.71
|
14
|
3 (21%)
|
0
|
Epinephrine
|
1 μM
|
7
|
1 (14%)
|
1 (14%)
|
−0.50#
|
5
|
0
|
0
|
Norepinephrine
|
1 μM
|
7
|
1 (14%)
|
0
|
−0.15#
|
5
|
0
|
0
|
hCG
|
100 IU/ml
|
10
|
3 (30%)
|
0
|
0.60
|
4
|
0
|
0
|
TSH
|
10 nM
|
4
|
0
|
0
|
−0.32
|
1
|
0
|
0
|
Glucagon
|
1 μM
|
4
|
0
|
0
|
0.50
|
1
|
0
|
0
|
GIP
|
100 nM
|
6
|
1 (17%)
|
1 (17%)
|
0.49¶
|
4
|
1 (25%)
|
0
|
- ¶ standard mixed meal, # upright posture test, † AVP im, n.a.: not applicable.